References
- Gastaldi M, Anais T, Vincent A. Antibody-mediated autoimmune encephalopathies and immunotherapies. Neurotherapeutics 2016;13:147–162.
- Miya, K, Takahushi Y, Mori H. Anti-NMDAR autoimmune encephalitis. Brain Dev 2014;36:645–652.
- Colley S, Smith J. Sore eyes and psychosis. BMJ Case Rep 2014;2014:bcr2013201956. doi: 10.1136/bcr-2013-201956.
- Zoccarato M, Saddi MV, Serra G, Pelizza MF, Rosellini I, Peddone L, Ticca A, Giometto B, Zuliani L. Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. J Neurol 2013;260:3185–3187. doi: 10.1007/s00415-013-7182-x.
- Motoyama R, Shiraishi K, Tanaka K, Kinoshita M, Tanaka M. [Anti-NMDA receptor antibody encephalitis with recurrent optic neuritis and epilepsy] [in Japanese]. Rinsho Shinkeigaku 2010;50:585–588.
- Kruer MC, Koch TK, Bourdette DN, Chabas D, Waubant E, Mueller S, Moscarello MA, Dalmau J, Woltjer RL, Adamus G. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology 2010;74:1473–1475. doi: 10.1212/WNL.0b013e3181dc1a7f.
- Sansig L, Tuzun F, Ko M, Baccon J, Lynch D, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007;3:291–296.
- Dalmau J, Lancaster E, Martinez-Hernandez E, Rosefeld M, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10:63–74. doi: 10.1016/S1474-4422(10)70253-2.
- Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157–165. doi: 10.1016/S1474-4422(12)70310-1.